Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ImmuCell Corporation

    NASDAQ: ICCC · Real-Time Price · USD
    6.32
    -0.03 (-0.47%)
    At close: Jun 17, 2025, 3:07 PM

    ImmuCell Statistics

    Share Statistics

    ImmuCell has 9.04M shares outstanding. The number of shares has increased by 14.08% in one year.

    Shares Outstanding

    n/a
    		 9.04M

    Shares Change (YoY)

    n/a
    		 14.08%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 14.76%

    Shares Floating

    n/a
    		 5.82M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,083

    FTD / Avg. Volume

    n/a
    		 12.36%

    Short Selling Information

    The latest short interest is 5.72K, so 0.06% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.72K

    Short % of Shares Out

    n/a
    		 0.06%

    Short % of Float

    n/a
    		 0.08%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -19.5 and the forward PE ratio is -59.36. ImmuCell's PEG ratio is 0.3.

    PE Ratio

    n/a
    		 -19.5

    Forward PE

    n/a
    		 -59.36

    PS Ratio

    n/a
    		 1.59

    Forward PS

    n/a
    		 3

    PB Ratio

    n/a
    		 1.53

    P/FCF Ratio

    n/a
    		 -390.09

    PEG Ratio

    n/a
    		 0.3
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ImmuCell.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.55.

    Current Ratio

    n/a
    		 3.41

    Quick Ratio

    n/a
    		 1.8

    Debt / Equity

    n/a
    		 0.55

    Debt / EBITDA

    n/a
    		 14.46

    Debt / FCF

    n/a
    		 -140.04

    Interest Coverage

    n/a
    		 -2.88

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $383,958.97

    Profits Per Employee

    n/a
    		 $-31,255.49

    Employee Count

    n/a
    		 69

    Asset Turnover

    n/a
    		 0.59

    Inventory Turnover

    n/a
    		 2.61

    Taxes

    Income Tax

    n/a
    		 10.06K

    Effective Tax Rate

    n/a
    		 -0.47%

    Stock Price Statistics

    The stock price has increased by 47.44% in the last 52 weeks. The beta is 0.31, so ImmuCell's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.31

    52-Week Price Change

    n/a
    		 47.44%

    50-Day Moving Average

    n/a
    		 5.71

    200-Day Moving Average

    n/a
    		 4.75

    Relative Strength Index (RSI)

    n/a
    		 56.27

    Average Volume (20 Days)

    n/a
    		 24,936

    Income Statement

    In the last 12 months, ImmuCell had revenue of 26.49M and earned -2.16M in profits. Earnings per share was -0.26.

    Revenue

    n/a
    		 26.49M

    Gross Profit

    n/a
    		 7.94M

    Operating Income

    n/a
    		 -1.64M

    Net Income

    n/a
    		 -2.16M

    EBITDA

    n/a
    		 1.04M

    EBIT

    n/a
    		 -1.62M

    Earnings Per Share (EPS)

    n/a
    		 -0.26
    Full Income Statement

    Balance Sheet

    The company has 3.76M in cash and 15.1M in debt, giving a net cash position of -11.34M.

    Cash & Cash Equivalents

    n/a
    		 3.76M

    Total Debt

    n/a
    		 15.1M

    Net Cash

    n/a
    		 -11.34M

    Retained Earnings

    n/a
    		 -14.16M

    Total Assets

    n/a
    		 45.62B

    Working Capital

    n/a
    		 12.05B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 357.9K and capital expenditures -465.73K, giving a free cash flow of -107.82K.

    Operating Cash Flow

    n/a
    		 357.9K

    Capital Expenditures

    n/a
    		 -465.73K

    Free Cash Flow

    n/a
    		 -107.82K

    FCF Per Share

    n/a
    		 -0.01
    Full Cash Flow Statement

    Margins

    Gross margin is 29.97%, with operating and profit margins of -6.19% and -8.14%.

    Gross Margin

    n/a
    		 29.97%

    Operating Margin

    n/a
    		 -6.19%

    Pretax Margin

    n/a
    		 -8.1%

    Profit Margin

    n/a
    		 -8.14%

    EBITDA Margin

    n/a
    		 3.94%

    EBIT Margin

    n/a
    		 -6.19%

    FCF Margin

    n/a
    		 -0.41%

    Dividends & Yields

    ICCC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ICCC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 25, 1990. It was a backward split with a ratio of 1:100.

    Last Split Date

    n/a
    		 Jul 25, 1990

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:100

    Scores

    Altman Z-Score

    n/a
    		 0.15

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist